The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
IMW 2019 | Promising outlook for MM patients
Gösta Gahrton
• 12 Sep 2019
Gösta Gahrton, MD, of Karolinska University Hospital, Stockholm, Sweden, talks about the outlook for multiple myeloma patients. Dr Gahrton suggests that new drugs should be combined with approaches such as allogeneic transplants, CAR-T cells and CAR-NK cells. This interview took place at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.
